The Role of Copy Number Variation in Susceptibility to Amyotrophic Lateral Sclerosis: Genome-Wide Association Study and Comparison with Published Loci

Background The genetic contribution to sporadic amyotrophic lateral sclerosis (ALS) has not been fully elucidated. There are increasing efforts to characterise the role of copy number variants (CNVs) in human diseases; two previous studies concluded that CNVs may influence risk of sporadic ALS, with multiple rare CNVs more important than common CNVs. A little-explored issue surrounding genome-wide CNV association studies is that of post-calling filtering and merging of raw CNV calls. We undertook simulations to define filter thresholds and considered optimal ways of merging overlapping CNV calls for association testing, taking into consideration possibly overlapping or nested, but distinct, CNVs and boundary estimation uncertainty. Methodology and Principal Findings In this study we screened Illumina 300K SNP genotyping data from 730 ALS cases and 789 controls for copy number variation. Following quality control filters using thresholds defined by simulation, a total of 11321 CNV calls were made across 575 cases and 621 controls. Using region-based and gene-based association analyses, we identified several loci showing nominally significant association. However, the choice of criteria for combining calls for association testing has an impact on the ranking of the results by their significance. Several loci which were previously reported as being associated with ALS were identified here. However, of another 15 genes previously reported as exhibiting ALS-specific copy number variation, only four exhibited copy number variation in this study. Potentially interesting novel loci, including EEF1D, a translation elongation factor involved in the delivery of aminoacyl tRNAs to the ribosome (a process which has previously been implicated in genetic studies of spinal muscular atrophy) were identified but must be treated with caution due to concerns surrounding genomic location and platform suitability. Conclusions and Significance Interpretation of CNV association findings must take into account the effects of filtering and combining CNV calls when based on early genome-wide genotyping platforms and modest study sizes.

[1]  A Al-Chalabi,et al.  Deletions of the heavy neurofilament subunit tail in amyotrophic lateral sclerosis. , 1999, Human molecular genetics.

[2]  K. Gunderson,et al.  High-resolution genomic profiling of chromosomal aberrations using Infinium whole-genome genotyping. , 2006, Genome research.

[3]  Lorraine Potocki,et al.  Characterization of Potocki-Lupski syndrome (dup(17)(p11.2p11.2)) and delineation of a dosage-sensitive critical interval that can convey an autism phenotype. , 2007, American journal of human genetics.

[4]  John W Griffin,et al.  DNA/RNA helicase gene mutations in a form of juvenile amyotrophic lateral sclerosis (ALS4). , 2004, American journal of human genetics.

[5]  J L Haines,et al.  Supporting Online Material Materials and Methods Figs. S1 to S7 Tables S1 to S4 References Mutations in the Fus/tls Gene on Chromosome 16 Cause Familial Amyotrophic Lateral Sclerosis , 2022 .

[6]  R. Ophoff,et al.  Analysis of genome-wide copy number variation in Irish and Dutch ALS populations. , 2008, Human molecular genetics.

[7]  Ewout J N Groen,et al.  Genome-wide association study identifies 19p13.3 (UNC13A) and 9p21.2 as susceptibility loci for sporadic amyotrophic lateral sclerosis , 2009, Nature Genetics.

[8]  Joseph T. Glessner,et al.  PennCNV: an integrated hidden Markov model designed for high-resolution copy number variation detection in whole-genome SNP genotyping data. , 2007, Genome research.

[9]  M. Ruberg,et al.  The G526R glycyl-tRNA synthetase gene mutation in distal hereditary motor neuropathy type V , 2006, Neurology.

[10]  Frank Baas,et al.  Genetic variation in DPP6 is associated with susceptibility to amyotrophic lateral sclerosis , 2008, Nature Genetics.

[11]  K. Fischbeck,et al.  Functional Analyses of Glycyl-tRNA Synthetase Mutations Suggest a Key Role for tRNA-Charging Enzymes in Peripheral Axons , 2006, The Journal of Neuroscience.

[12]  Xun Hu,et al.  TDP-43 Mutations in Familial and Sporadic Amyotrophic Lateral Sclerosis , 2008, Science.

[13]  J. Haines,et al.  Mutations in Cu/Zn superoxide dismutase gene are associated with familial amyotrophic lateral sclerosis , 1993, Nature.

[14]  K. Brew,et al.  Characterization of human angiogenin variants implicated in amyotrophic lateral sclerosis. , 2007, Biochemistry.

[15]  J. Thevelein,et al.  Disrupted function and axonal distribution of mutant tyrosyl-tRNA synthetase in dominant intermediate Charcot-Marie-Tooth neuropathy , 2006, Nature Genetics.

[16]  M. Daly,et al.  Identifying Relationships among Genomic Disease Regions: Predicting Genes at Pathogenic SNP Associations and Rare Deletions , 2009, PLoS genetics.

[17]  A. Al-Chalabi,et al.  Genetic studies of amyotrophic lateral sclerosis: Controversies and perspectives , 2009, Amyotrophic lateral sclerosis : official publication of the World Federation of Neurology Research Group on Motor Neuron Diseases.

[18]  T. Gillingwater,et al.  A mutation in the vesicle-trafficking protein VAPB causes late-onset spinal muscular atrophy and amyotrophic lateral sclerosis. , 2004, American journal of human genetics.

[19]  Joshua M. Korn,et al.  Integrated detection and population-genetic analysis of SNPs and copy number variation , 2008, Nature Genetics.

[20]  C. Yau,et al.  QuantiSNP: an Objective Bayes Hidden-Markov Model to detect and accurately map copy number variation using SNP genotyping data , 2007, Nucleic acids research.

[21]  R. Ophoff,et al.  ITPR2 as a susceptibility gene in sporadic amyotrophic lateral sclerosis: a genome-wide association study , 2007, The Lancet Neurology.

[22]  I. Glass,et al.  Senataxin, the yeast Sen1p orthologue: Characterization of a unique protein in which recessive mutations cause ataxia and dominant mutations cause motor neuron disease , 2006, Neurobiology of Disease.

[23]  V. Meininger,et al.  Variants of the heavy neurofilament subunit are associated with the development of amyotrophic lateral sclerosis. , 1994, Human molecular genetics.

[24]  Pall I. Olason,et al.  A human phenome-interactome network of protein complexes implicated in genetic disorders , 2007, Nature Biotechnology.

[25]  A. C. Chinault,et al.  Homologous recombination of a flanking repeat gene cluster is a mechanism for a common contiguous gene deletion syndrome , 1997, Nature Genetics.

[26]  D. Geschwind,et al.  Novel Mutations in TARDBP (TDP-43) in Patients with Familial Amyotrophic Lateral Sclerosis , 2008, PLoS genetics.

[27]  Judy H Cho,et al.  Deletion polymorphism upstream of IRGM associated with altered IRGM expression and Crohn's disease , 2008, Nature Genetics.

[28]  B. McConkey,et al.  TARDBP mutations in individuals with sporadic and familial amyotrophic lateral sclerosis , 2008, Nature Genetics.

[29]  A. Al-Chalabi,et al.  Amyotrophic lateral sclerosis in an urban setting: a population based study of inner city London. , 2006, Journal of neurology.

[30]  J. Slade,et al.  Novel insertion in the KSP region of the neurofilament heavy gene in amyotrophic lateral sclerosis (ALS) , 1998, Neuroreport.

[31]  K. Bushby,et al.  Spastin and paraplegin gene analysis in selected cases of motor neurone disease (MND) , 2003, Amyotrophic lateral sclerosis and other motor neuron disorders : official publication of the World Federation of Neurology, Research Group on Motor Neuron Diseases.

[32]  Lude Franke,et al.  Copy-number variation in sporadic amyotrophic lateral sclerosis: a genome-wide screen , 2008, The Lancet Neurology.

[33]  S. Ennis,et al.  ANG mutations segregate with familial and 'sporadic' amyotrophic lateral sclerosis , 2006, Nature Genetics.

[34]  Zachary A. Szpiech,et al.  Genotype, haplotype and copy-number variation in worldwide human populations , 2008, Nature.

[35]  R. Ophoff,et al.  Reduced expression of the Kinesin-Associated Protein 3 (KIFAP3) gene increases survival in sporadic amyotrophic lateral sclerosis , 2009, Proceedings of the National Academy of Sciences.

[36]  Pablo Tamayo,et al.  Gene set enrichment analysis: A knowledge-based approach for interpreting genome-wide expression profiles , 2005, Proceedings of the National Academy of Sciences of the United States of America.

[37]  M. Hayden,et al.  Mutation screening of the ALS2 gene in sporadic and familial amyotrophic lateral sclerosis. , 2003, Archives of neurology.

[38]  M. Province,et al.  Avoiding the high Bonferroni penalty in genome‐wide association studies , 2009, Genetic epidemiology.

[39]  J. Haines,et al.  Linkage of recessive familial amyotrophic lateral sclerosis to chromosome 2q33–q35 , 1994, Nature Genetics.

[40]  M. Pericak-Vance,et al.  The gene encoding alsin, a protein with three guanine-nucleotide exchange factor domains, is mutated in a form of recessive amyotrophic lateral sclerosis , 2001, Nature Genetics.

[41]  J. Haines,et al.  Linkage of a gene causing familial amyotrophic lateral sclerosis to chromosome 21 and evidence of genetic-locus heterogeneity. , 1991, The New England journal of medicine.

[42]  Kai Wang,et al.  Pathway-based approaches for analysis of genomewide association studies. , 2007, American journal of human genetics.

[43]  D. Campana,et al.  Mutations in the Human λ5/14.1 Gene Result in B Cell Deficiency and Agammaglobulinemia , 1998, The Journal of experimental medicine.

[44]  Louise V Wain,et al.  Genomic copy number variation, human health, and disease , 2009, The Lancet.

[45]  A. Iafrate,et al.  Angiogenin loss‐of‐function mutations in amyotrophic lateral sclerosis , 2007, Annals of neurology.

[46]  Joseph A. Gogos,et al.  Strong association of de novo copy number mutations with sporadic schizophrenia , 2008, Nature Genetics.

[47]  B. Castellotti,et al.  Identification of new ANG gene mutations in a large cohort of Italian patients with amyotrophic lateral sclerosis , 2008, Neurogenetics.

[48]  C. Andres,et al.  Abnormal SMN1 gene copy number is a susceptibility factor for amyotrophic lateral sclerosis , 2002, Annals of neurology.

[49]  G. Rouleau,et al.  Oxidized/misfolded superoxide dismutase‐1: the cause of all amyotrophic lateral sclerosis? , 2007, Annals of neurology.

[50]  M. Stephens,et al.  High-Resolution Mapping of Expression-QTLs Yields Insight into Human Gene Regulation , 2008, PLoS genetics.

[51]  L. Feuk,et al.  Detection of large-scale variation in the human genome , 2004, Nature Genetics.

[52]  R. Ophoff,et al.  Variants of the elongator protein 3 (ELP3) gene are associated with motor neuron degeneration , 2008, Human molecular genetics.

[53]  C. Hayward,et al.  Molecular genetic analysis of the APEX nuclease gene in amyotrophic lateral sclerosis , 1999, Neurology.